SPARK Microgravity is Building an Orbital Cancer Lab — and It’s a Perfect Fit for the New Commercial Space Stations
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
The clear ROI of orbital labs for oncology R&D.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
Step-by-step guide to launching your first microgravity research mission.
How cancer's behavior in space reveals new therapeutic targets.
Cancer’s challenge and why SPARK is researching it in space?
Two female founders are pioneering the next frontier in oncology.
Solving "Undruggable" Targets with Perfect Crystals
Why space research is essential, not obsolete, for modern oncology.
SPARK Microgravity’s leadership engaged with partners including Atmos Space Cargo, Space Cargo Unlimited, and Merck Sharp & Dohme (MSD)
SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos
How microgravity enables better drug design and novel therapeutic formulations.
SPARK Microgravity has successfully completed its integration campaign with Swedish Space Corporation (SSC).
SPARK’s presence at Frontiers Science House reflects a broader momentum around the company as it continues to develop its orbital oncology platform.
Real case studies prove ROI of microgravity-enabled pharma innovation.
Unlocking Cancer’s Secrets in Microgravity
Why 2D and animal models fail and how microgravity bridges translation.
How removing gravity reveals new insights in cancer research.
A data-driven look at the market for orbital oncology research.
Allison Bajet, joined an exceptional group of internationally recognized space leaders at Frontiers Science House in Davos for the session “The Space Technology Revolution".
Meet the startup who won #1 EU Deep Tech Award 2025
SPARK Microgravity GmbH has clinched the top honor at the Barcelona Deep Tech Summit 2025, taking home the #1 EU Deep Tech Champion Award.
How microgravity enables better drug design and novel formulations.
How microgravity reveals truer tumor behavior than traditional models.
SPARK Microgravity's co-founders share their space research mission during an interview at Barcelona Deep Tech Week 2025.
SPARK Microgravity Brings Orbital Oncology Vision to ORBIT FOR LIFE Roundtable at Roche Diagnostics
Solving "Undruggable" Targets with Perfect Crystals
Unlocking Cancer’s Secrets in Microgravity
Cancer’s challenge and why SPARK is researching it in space?
The clear ROI of orbital labs for oncology R&D.
How microgravity enables better drug design and novel therapeutic formulations.
How removing gravity reveals new insights in cancer research.
Two female founders are pioneering the next frontier in oncology.
A data-driven look at the market for orbital oncology research.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
Why 2D and animal models fail and how microgravity bridges translation.
How microgravity reveals truer tumor behavior than traditional models.
Step-by-step guide to launching your first microgravity research mission.
Real case studies prove ROI of microgravity-enabled pharma innovation.
How cancer's behavior in space reveals new therapeutic targets.
How microgravity enables better drug design and novel formulations.
Why space research is essential, not obsolete, for modern oncology.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
From orbit to clinic, let’s launch the future of healthcare, together.
.svg)
